Hepatocellular adenomas in a large community population, 2000 to 2010: Reclassification per current World Health Organization classification and results of long-term follow-up

Human Pathology

Volumn 45, Issue 5, 2014, Pages 976-983

  Shafizadeh, Nafis ^a   Genrich, Gillian ^b   Ferrell, Linda ^b   Kakar, Sanjay ^c  

^a WOODLAND HILLS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Hepatocellular adenoma; HNF1 ; Immunohistochemistry; Inflammatory; catenin

Indexed keywords

HEPATOCELLULAR ADENOMA; HNF1Α; IMMUNOHISTOCHEMISTRY; INFLAMMATORY; Β-CATENIN;

ADENOMA, LIVER CELL; ADOLESCENT; ADULT; AGED; BETA CATENIN; CALIFORNIA; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOCAL NODULAR HYPERPLASIA; FOLLOW-UP STUDIES; GLUTAMATE-AMMONIA LIGASE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HOSPITALS, COMMUNITY; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIVER NEOPLASMS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; WORLD HEALTH ORGANIZATION;

EID: 84898820800     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.12.011     Document Type: Article

References (28)

1. P. Bioulac-Sage, S. Rebouissou, and C. Thomas et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry Hepatology 46 2007 Sep 740 748
2. J. Zucman-Rossi, E. Jeannot, and J.T. Nhieu et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC Hepatology 43 2006 Mar 515 524
3. G. Courtois, J.G. Morgan, L.A. Campbell, G. Fourel, and G.R. Crabtree Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters Science 238 1987 688 692
4. O. Bluteau, E. Jeannot, and P. Bioulac-Sage et al. Bi-allelic inactivation of TCF1 in hepatic adenomas Nat Genet 32 2002 Oct 312 315
5. Y. Bacq, E. Jacquemin, and C. Balabaud et al. Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation Gastroenterology 125 2003 Nov 1470 1475
6. Y. Reznik, T. Dao, and R. Coutant et al. Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families J Clin Endocrinol Metab 89 2004 Mar 1476 1480
7. S. Rebouissou, M. Amessou, and G. Couchy et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours Nature 457 2009 Jan 8 200 204
8. Joseph NM, Ferrell LD, Jain D, et al. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma. Mod Pathol 2013 Jun 28; http://dx.doi.org/10.1038/modpathol.2013.114.
9. V. Paradis, A. Champault, and M. Ronot et al. Telangiectatic adenoma: an entity associated with increased body mass index and inflammation Hepatology 46 2007 Jul 140 146
10. K.J. Evason, J.P. Grenert, L.D. Ferrell, and S. Kakar Atypical hepatocellular adenoma-like neoplasms with beta-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas Hum Pathol 44 2013 May 750 758
11. C. Balabaud, W. Al-Rabih, and P. Chen et al. Focal nodular hyperplasia and hepatocellular adenoma around the world viewed through the scope of immunopathologic classification International Journal of Hepatology 2013 2013 Jan 1 12
12. C.Y. Chang, J.C. Hernandez-Prera, S. Roayaie, M. Schwartz, and S.N. Thung Changing epidemiology of hepatocellular adenoma in the United States: review of the literature Int J Hepatol 2013 2013 604860
13. L. Ferrell Liver pathology: cirrhosis, hepatitis, and primary liver tumors Update and diagnostic problems. Mod Pathol 13 2000 Jun 679 704
14. Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 1995 Sep;22:983-93.
15. P. Bioulac-Sage, G. Cubel, and S. Taouji et al. Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes Am J Surg Pathol 36 2012 Nov 1691 1699
16. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th ed. Lyon: 2010.
17. B.R. Balsara, J. Pei, and R.A. De et al. Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1 Genes Chromosomes Cancer 30 2001 Mar 245 253
18. T.C. Poon, N. Wong, P.B. Lai, M. Rattray, P.J. Johnson, and J.J. Sung A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data Gastroenterology 131 2006 Oct 1262 1270
19. S. Kakar, X. Chen, and C. Ho et al. Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms Histopathology 55 2009 Aug 197 205
20. L. Wilkens, M. Bredt, and P. Flemming et al. Diagnostic impact of fluorescence in situ hybridization in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma J Mol Diagn 3 2001 May 68 73
21. L. Wilkens, M. Bredt, P. Flemming, T. Becker, J. Klempnauer, and H.H. Kreipe Differentiation of liver cell adenomas from well-differentiated hepatocellular carcinomas by comparative genomic hybridization J Pathol 193 2001 Apr 476 482
22. V. Audard, G. Grimber, and C. Elie et al. Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations J Pathol 212 2007 Jul 345 352
23. B.B. Dal, L. Rosa, and N. Campanini et al. Glutamine synthetase immunostaining correlates with pathologic features of hepatocellular carcinoma and better survival after radiofrequency thermal ablation Clin Cancer Res 16 2010 Apr 1 2157 2166
24. O. Farges, N. Ferreira, S. Dokmak, J. Belghiti, P. Bedossa, and V. Paradis Changing trends in malignant transformation of hepatocellular adenoma Gut 60 2011 Jan 85 89
25. P. Bioulac-Sage, H. Laumonier, and A. Rullier et al. Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology Liver Int 29 2009 Mar 459 465
26. A. Shanbhogue, S.N. Shah, A. Zaheer, S.R. Prasad, N. Takahashi, and R. Vikram Hepatocellular adenomas: current update on genetics, taxonomy, and management J Comput Assist Tomogr 35 2011 Mar 159 166
27. S.J. Cho, L.D. Ferrell, and R.M. Gill Expression of liver fatty acid binding protein (LFABP) in hepatocellular carcinomas 2013 Mar 6 Abstract at the United States and Canadian Academy of Pathology Annual Meeting Baltimore
28. C.O. Bellamy, R.S. Maxwell, S. Prost, I.A. Azodo, J.J. Powell, and J.R. Manning The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centre Histopathology 62 2013 Feb 431 445